Fifteen years of research on preventing HIV infection among injecting drug users: What we have learned, what we have not learned, what we have done, what we have not done

被引:0
|
作者
Des Jarlais, DC
Friedman, SR
机构
[1] Beth Israel Deaconess Med Ctr, Inst Chem Dependency, New York, NY 10003 USA
[2] Albert Einstein Coll Med, New York, NY 10461 USA
[3] Natl Dev & Res Inst Inc, New York, NY 10013 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective, Acquired immunodeficiency syndrome (AIDS) was formally identified among injecting drug users (IDUs) in 1981, and research on preventing human immunodeficiency virus (HIV) infection among drug injectors began shortly thereafter. At the time this research was begun, there was a general assumption that drug users (who were called drug abusers at that time) were too self-destructive and their behavior too chaotic for them to change their behavior to avoid infection with HIV, This chapter reviews the history of research on implementation of programs for prevention of HIV infection among IDUs, Methods. Reviews of both research and program implementation research were conducted, Consultative discussions of issues and findings were conducted with researchers in the United Stales and other countries. Results. An extremely large amount of useful information has accumulated during the past 15 years, We now know that the great majority of IDUs will change their injecting behavior in response to the threat of AIDS and that these behavior changes are effective in reducing HIV transmission among drug injectors, Additional insight is needed regarding the apparent insufficiency of some prevention programs to control HIV, the transmission dynamics of rapid HIV spread, and the persistence of moderate to high incidence of HIV infection in high seroprevalence populations. Despite the current research knowledge base, implementation of effective prevention programs in many countries is nonexistent to incomplete. Conclusion. The most important barrier to reducing HIV transmission among drug injectors is not a lack of knowledge but the failure to implement effective prevention programs in many parts of the world.
引用
收藏
页码:182 / 188
页数:7
相关论文
共 50 条
  • [1] Disaster Simulation: What We Have Done and What We Have Learned
    Mellucci, Pedro L.
    Netto, Willy J. Macedo
    Pereira, Fernando L.
    Campos, Alexandre S.
    Laursen, Bruna M.
    Sannino, Camila P.
    Rodrigues, Isabella B.
    Seribeli, Juliana
    Pinotti, Keiny S.
    Queiroz, Lyara Mm
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) : S113 - S113
  • [2] Heterosis - What have we learned? What have we done? Where are we headed?
    Hallauer, AR
    [J]. GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, 1999, : 483 - 492
  • [3] Chernobyl and Fukushima nuclear accidents: What have we learned and what have we done?
    Djurovic, Branka
    Radjen, Slavica
    Radenkovic, Mirjana
    Dragovic, Tamara
    Tatomirovic, Zeljka
    Ivankovic, Negovan
    Vukmirovic, Djordje
    Dugonjic, Sanja
    [J]. VOJNOSANITETSKI PREGLED, 2016, 73 (05) : 484 - 490
  • [4] What have we said? What have we done?
    Lehmann, Jennifer
    Redshaw, Lorraine
    [J]. CHILDREN AUSTRALIA, 2005, 30 (03) : 4 - 9
  • [5] What Have We Done?
    Schindler, Fred
    [J]. IEEE MICROWAVE MAGAZINE, 2024, 25 (09) : 18 - 19
  • [6] WHAT HAVE WE DONE
    SHELLEY, D
    [J]. NEW STATESMAN & SOCIETY, 1993, 6 (278): : 20 - 22
  • [7] What Have We Done
    Hoffert, Barbara
    [J]. LIBRARY JOURNAL, 2022, 147 (10) : 112 - 112
  • [8] What we have done
    Soldatic, Karen
    [J]. DISABILITY & SOCIETY, 2012, 27 (06) : 895 - 897
  • [9] 'WHAT WE HAVE DONE'
    BAIRD, A
    [J]. PARIS REVIEW, 1996, (139): : 121 - 121
  • [10] What have we done?
    不详
    [J]. NATION, 2004, 278 (12) : 3 - 4